GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » ARYA Sciences Acquisition Corp III (NAS:ARYA) » Definitions » Financial Strength

ARYA Sciences Acquisition III (ARYA Sciences Acquisition III) Financial Strength : 0 (As of Mar. 2021)


View and export this data going back to 2020. Start your Free Trial

What is ARYA Sciences Acquisition III Financial Strength?

ARYA Sciences Acquisition III has the Financial Strength Rank of 0.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

ARYA Sciences Acquisition III has no long-term debt (1). As of today, ARYA Sciences Acquisition III's Altman Z-Score is 0.00.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.


Competitive Comparison of ARYA Sciences Acquisition III's Financial Strength

For the Shell Companies subindustry, ARYA Sciences Acquisition III's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ARYA Sciences Acquisition III's Financial Strength Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, ARYA Sciences Acquisition III's Financial Strength distribution charts can be found below:

* The bar in red indicates where ARYA Sciences Acquisition III's Financial Strength falls into.



ARYA Sciences Acquisition III Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

ARYA Sciences Acquisition III's Interest Expense for the months ended in Mar. 2021 was $0.00 Mil. Its Operating Income for the months ended in Mar. 2021 was $-1.78 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2021 was $0.00 Mil.

ARYA Sciences Acquisition III's Interest Coverage for the quarter that ended in Mar. 2021 is

ARYA Sciences Acquisition III had no long-term debt (1).

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

ARYA Sciences Acquisition III's Debt to Revenue Ratio for the quarter that ended in Mar. 2021 is

Debt to Revenue Ratio=Total Debt (Q: Mar. 2021 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 0) / 0
=N/A

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

ARYA Sciences Acquisition III has a Z-score of 0.00, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ARYA Sciences Acquisition III  (NAS:ARYA) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

ARYA Sciences Acquisition III has the Financial Strength Rank of 0.


ARYA Sciences Acquisition III Financial Strength Related Terms

Thank you for viewing the detailed overview of ARYA Sciences Acquisition III's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


ARYA Sciences Acquisition III (ARYA Sciences Acquisition III) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
51 Astor Place, 10th Floor, New York, NY, USA, 10003
Website
ARYA Sciences Acquisition Corp III is a blank check company.
Executives
Adam Leo Stone director, 10 percent owner, officer: Chief Executive Officer C/O SOLID BIOSCIENCES, LLC, 141 PORTLAND STREET, FIFTH FLOOR, CAMBRIDGE MA 02139
Michael Seth Altman director, 10 percent owner, officer: Chief Financial Officer C/O PERCEPTIVE ADVISORS, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Arya Sciences Holdings Iii 10 percent owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Saqib Islam director ALEXION PHARMACEUTICALS, 352 KNOTTER DRIVE, CHESHIRE CT 06410
Joseph Edelman director C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Todd Wider director 4848 LEMMON AVENUE, SUITE 517, DALLAS TX 75219
Bradley L Campbell director C/O AMICUS THERAPEUTICS, INC., 1 CEDAR BROOK DRIVE, CRANBURY NJ 08512
Konstantin Poukalov officer: Chief Business Officer C/O KADMON HOLDINGS, LLC, 450 E 29TH STREET, NEW YORK NY 10016